Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Bortezomib Inhibits Human Osteoclastogenesis.

Ivana Zavrski, MD, Monica Hecht, PhD, Holger Krebbel, Claudia Fleissner, MD, Maren Mieth, PhD, Martin Kaiser, MD, Ulrike Heider, MD, Christian Jakob, MD, Jan Sterz, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2006) 108 (11): 1395.

https://doi.org/10.1182/blood.V108.11.1395.1395

Published: 2006

Journal Articles

Synergistic Interaction of the Histone Deacetylase Inhibitor SAHA with the Proteasome Inhibitor Bortezomib in Mantle Cell Lymphoma.

Ulrike Heider, MD, Martin Kaiser, MD, Ivana Zavrski, MD, Jan Sterz, MD, Christian Jakob, MD, Claudia Fleissner, MD, Monica Hecht, MD, Lorenz Kleeberg, MD, Christian Braun, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2006) 108 (11): 2509.

https://doi.org/10.1182/blood.V108.11.2509.2509

Published: 2006

Journal Articles

BSc2118, a Novel Proteasome Inhibitor, Shows Anti-Tumor Activity in Multiple Myeloma and Mantle Cell Lymphoma.

Jan Sterz, MD, Christian Jakob, MD, Ulrike Kuckelkorn, PhD, Hannes A. Braun, PhD, Martin Kaiser, MD, Claudia Fleissner, MD, Lorenz Kleeberg, MD, Ulrike Heider, MD, Kurt Possinger, MD, Peter M. Kloetzel, PhD, Orhan Sezer, MD, Ivana Zavrski, MD

Blood (2006) 108 (11): 3475.

https://doi.org/10.1182/blood.V108.11.3475.3475

Published: 2006

Journal Articles

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18

Hongyu Liu, Chuanbing Zang, Martin H. Fenner, Dachuan Liu, Kurt Possinger, H. Phillip Koeffler, Elena Elstner

Blood (2006) 107 (9): 3683–3692.

https://doi.org/10.1182/blood-2005-05-2103

Published: 2006

Journal Articles

Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.

Ulrike Heider, MD, Martin Kaiser, MD, Christian Müller, MD, Carsten-Oliver Schulz, MD, Christian Jakob, MD, Ivana Zavrski, MD, Jan Eucker, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2005) 106 (11): 3457.

https://doi.org/10.1182/blood.V106.11.3457.3457

Published: 2005

Journal Articles

Valproic Acid Inihibts Histone Deacetylases and Proliferation and Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.

Martin Kaiser, MD, Ulrike Heider, MD, Ivana Zavrski, MD, Jan Sterz, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2005) 106 (11): 5165.

https://doi.org/10.1182/blood.V106.11.5165.5165

Published: 2005

Journal Articles

Bortezomib (PS-341) Sensitizes Multiple Myeloma Cell Lines to Etoposide-Induced Apoptosis.

Ivana Zavrski, MD, Martin Kaiser, MD, Marleen Rosche, MD, Ulrike Heider, MD, Christian Jakob, MD, Claudia Fleissner, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2005) 106 (11): 5166.

https://doi.org/10.1182/blood.V106.11.5166.5166

Published: 2005

Journal Articles

Histone Deacetylase Inhibitors Induce Growth Inhibition, Cell Cycle Arrest and Apoptosis in Mantle Cell Lymphoma and Reduce VEGF Production.

Ulrike Heider, MD, Martin Kaiser, MD, Ivana Zavrski, MD, Jan Sterz, MD, Christian Jakob, MD, Claudia Fleissner, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2005) 106 (11): 4817.

https://doi.org/10.1182/blood.V106.11.4817.4817

Published: 2005

Journal Articles

Serum Total-RANKL Is Elevated in Patients with Multiple Myeloma, Increases with ISS Stage and Decreases after Induction Therapy.

Christian Jakob, MD, Jan Sterz, MD, Lorenz Kleeberg, MD, Ivana Zavrski, MD, Martin Kaiser, MD, Jan Eucker, MD, Ulrike Heider, MD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2005) 106 (11): 2511.

https://doi.org/10.1182/blood.V106.11.2511.2511

Published: 2005

Journal Articles

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Jan Eucker, MD, Katharina Baengeroth, Ivana Zavrski, MD, Holger Krebbel, Chuanbing Zang, PhD, Ulrike Heider, MD, Christian Jakob, MD, Elena Elstner, PhD, Kurt Possinger, MD, Orhan Sezer, MD

Blood (2004) 104 (11): 4848.

https://doi.org/10.1182/blood.V104.11.4848.4848

Published: 2004

Journal Articles

Induction of Growth Inhibition and Apoptosis by TZD18, a Novel Dual Ligand for PPAR alpha/gamma, in Human Ph-Positive ALL Cells In Vitro .

Elena Elstner, PhD, Hongyu Liu, MS, Chuanbing Zang, PhD, Dachuan Liu, MS, Shunnan Xu, Martin H. Fenner, MD, Kurt Possinger, MD

Blood (2004) 104 (11): 2088.

https://doi.org/10.1182/blood.V104.11.2088.2088

Published: 2004

Journal Articles

Circulating Proteasome Level Is an Independent Prognostic Factor for Survival in Patients with Multiple Myeloma.

Christian Jakob, MD, Karl Egerer, PhD, Eugen Feist, MD, Ivana Zavrski, MD, Jan Eucker, MD, Ulrike Heider, MD, Gerd Burmester, MD, Kurt Possinger, MD, Peter M. Kloetzel, PhD, Orhan Sezer, MD

Blood (2004) 104 (11): 1486.

https://doi.org/10.1182/blood.V104.11.1486.1486

Published: 2004

Journal Articles

Immunocytochemistry reveals RANKL expression of myeloma cells

Orhan Sezer, Ulrike Heider, Christian Jakob, Ivana Zavrski, Jan Eucker, Kurt Possinger, Christine Sers, Veit Krenn

Blood (2002) 99 (12): 4646–4647.

https://doi.org/10.1182/blood-2002-01-0148

Published: 2002

Journal Articles

Fulminant Intravascular Disseminating Malignant Melanoma Mimicking Acute Leukemia

Uwe Trefzer, Christina Schlegel, Wolfram Sterry, Ernst Späth-Schwalbe, Kurt Possinger, Carsten Denkert

Blood (1999) 94 (4): 1483–1484.

https://doi.org/10.1182/blood.V94.4.1483

Published: 1999

NARROW

Bortezomib Inhibits Human Osteoclastogenesis.

Synergistic Interaction of the Histone Deacetylase Inhibitor SAHA with the Proteasome Inhibitor Bortezomib in Mantle Cell Lymphoma.

BSc2118, a Novel Proteasome Inhibitor, Shows Anti-Tumor Activity in Multiple Myeloma and Mantle Cell Lymphoma.

Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPARα/γ ligand TZD18

Treatment of Bortezomib Increases Osteoblast Function in Patients with Multiple Myeloma.

Valproic Acid Inihibts Histone Deacetylases and Proliferation and Induces Cell Cycle Arrest and Apoptosis in Multiple Myeloma.

Bortezomib (PS-341) Sensitizes Multiple Myeloma Cell Lines to Etoposide-Induced Apoptosis.

Histone Deacetylase Inhibitors Induce Growth Inhibition, Cell Cycle Arrest and Apoptosis in Mantle Cell Lymphoma and Reduce VEGF Production.

Serum Total-RANKL Is Elevated in Patients with Multiple Myeloma, Increases with ISS Stage and Decreases after Induction Therapy.

Induction of Apoptosis in Multiple Myeloma by Ligands of Peroxisome Proliferator-Activated Receptor γ (PPAR-γ).

Induction of Growth Inhibition and Apoptosis by TZD18, a Novel Dual Ligand for PPAR alpha/gamma, in Human Ph-Positive ALL Cells In Vitro .

Circulating Proteasome Level Is an Independent Prognostic Factor for Survival in Patients with Multiple Myeloma.

Immunocytochemistry reveals RANKL expression of myeloma cells

Fulminant Intravascular Disseminating Malignant Melanoma Mimicking Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only